Sangamo Therapeutics, Inc.
SGMO
$0.6565
$0.03425.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.92M | 39.20M | 27.79M | 54.42M | 81.00M |
| Total Receivables | 4.60M | 10.50M | 581.00K | 691.00K | 4.07M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.18M | 8.43M | 11.71M | 12.61M | 9.26M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 916.00K | -- |
| Total Current Assets | 51.69M | 58.13M | 40.08M | 68.64M | 94.33M |
|
|
|||||
| Total Current Assets | 51.69M | 58.13M | 40.08M | 68.64M | 94.33M |
| Net Property, Plant & Equipment | 34.76M | 36.91M | 39.29M | 42.95M | 52.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.19M | 16.22M | 13.65M | 17.37M | 18.13M |
| Total Assets | 101.64M | 111.26M | 93.01M | 128.96M | 165.32M |
|
|
|||||
| Total Accounts Payable | 15.49M | 19.79M | 17.59M | 15.47M | 15.26M |
| Total Accrued Expenses | 17.56M | 21.99M | 16.37M | 17.30M | 16.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.31M | -- | -- | -- | 4.59M |
| Total Finance Division Other Current Liabilities | 8.45M | 1.38M | 5.05M | 7.47M | 11.73M |
| Total Other Current Liabilities | 8.45M | 1.38M | 5.05M | 7.47M | 11.73M |
| Total Current Liabilities | 45.81M | 43.16M | 39.01M | 40.24M | 47.73M |
|
|
|||||
| Total Current Liabilities | 45.81M | 43.16M | 39.01M | 40.24M | 47.73M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 26.25M | 27.73M | 29.10M | 30.82M | 33.52M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.81M | 1.24M | 1.22M | 1.21M | 1.19M |
| Total Liabilities | 78.87M | 72.13M | 69.32M | 72.26M | 82.43M |
|
|
|||||
| Common Stock & APIC | 1.53B | 1.52B | 1.52B | 1.52B | 1.49B |
| Retained Earnings | -1.50B | -1.48B | -1.49B | -1.46B | -1.41B |
| Treasury Stock & Other | -7.53M | -4.22M | -5.88M | -5.80M | -4.60M |
| Total Common Equity | 22.77M | 39.13M | 23.69M | 56.70M | 82.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.77M | 39.13M | 23.69M | 56.70M | 82.89M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.77M | 39.13M | 23.69M | 56.70M | 82.89M |
|
|
|||||
